Serum levels of sL-selectin and tumour necrosis factor-α in children with type 1 diabetes mellitus

被引:6
|
作者
Dursun, H. [1 ]
Cinaz, P.
Bideci, A.
Guven, A.
Aybay, C.
Elbeg, S.
机构
[1] Gazi Univ, Sch Med, Dept Pediat Endocrinol, Ankara, Turkey
[2] Gazi Univ, Sch Med, Dept Pediat Immunol, Ankara, Turkey
[3] Gazi Univ, Sch Med, Dept Pediat Nucl Med, Ankara, Turkey
关键词
sL-selectin; tumour necrosis factor-alpha; Type 1 diabetes mellitus;
D O I
10.1007/s00592-007-0233-y
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Type I diabetes mellitus (DM) is a result of inflammation and destruction of (x-cells in the pancreatic islet cells. The aim of this study is to evaluate the associations of diabetes with soluble L-selectin (sL-selectin) and tumour necrosis factor-alpha (TNF-alpha) in children with type I DM; and also to evaluate the associations of these parameters with the disease period, glycaemic control, late and puberty stage. Serum sL-selectin and TNF-alpha levels were measured in 44 children with type I DM and 44 healthy children. Neither the patients nor the control group showed significant difference between the levels of sL-selectin and TNF-alpha (sequence mean 12.17 +/- 1.62 ng/ml vs. 12.62 +/- 1.56 ng/ml and 7.27 +/- 3.1 pg/ml vs. 7.88 +/- 2.7 pg/ml). There was no statistically significant difference between children with duration of diabetes longer than 5 years and children with duration of diabetes shorter than I year. There was also no statistically significant difference between poor glycaemic control and good-acceptable glycaemic control patients. The present results indicate that sL-selectin and TNF-alpha serum levels are not increased and cannot be used as prognostic predictors in type I DM; and also sL-selectin and TNF-alpha. do not change with the disease period, glycaemic control state and puberty stage.
引用
收藏
页码:1 / 5
页数:5
相关论文
共 50 条
  • [31] Relationship between serum tumor necrosis factor-α and insulin resistance in obese men with Type 2 diabetes mellitus
    Mishima, Y
    Kuyama, A
    Tada, A
    Takahashi, K
    Ishioka, T
    Kibata, M
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2001, 52 (02) : 119 - 123
  • [32] Serum tumour necrosis factor-α levels in cancer patients are discontinuous and correlate with weight loss
    Bossola, M
    Muscaritoli, M
    Bellantone, R
    Pacelli, F
    Cascino, A
    Sgadari, A
    Battaglia, F
    Piccioni, E
    Scambia, G
    Doglietto, GB
    Fanelli, FR
    EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2000, 30 (12) : 1107 - 1112
  • [33] Serum interleukin 18 and tumour necrosis factor-α levels are increased in Behcet's disease
    Oztas, MO
    Onder, M
    Gurer, MA
    Bukan, N
    Sancak, B
    CLINICAL AND EXPERIMENTAL DERMATOLOGY, 2005, 30 (01) : 61 - 63
  • [34] Increased Serum Tumour Necrosis Factor-α in Hidradenitis Suppurativa Patients: Is There a Basis for Treatment with Anti-Tumour Necrosis Factor-α Agents?
    Matusiak, Lukasz
    Bieniek, Andrzej
    Szepietowski, Jacek C.
    ACTA DERMATO-VENEREOLOGICA, 2009, 89 (06) : 601 - 603
  • [35] Threshold serum concentrations of tumour necrosis factor alpha (TNFα) as a potential marker of the presence of microangiopathy in children and adolescents with type 1 diabetes mellitus (T1DM)
    Zorena, Katarzyna
    Kula, Marta
    Malinowska, Ewa
    Raczynska, Dorota
    Mysliwiec, Malgorzata
    Raczynska, Krystyna
    HUMAN IMMUNOLOGY, 2013, 74 (01) : 75 - 81
  • [36] Serum Levels of Basic Fibroblast Growth Factor and Vascular Endothelial Growth Factor in Children and Adolescents with Type 1 Diabetes Mellitus
    Ariadne Malamitsi-Puchner
    Angeliki Sarandakou
    John Tziotis
    Chrysoula Dafogianni
    Christos S Bartsocas
    Pediatric Research, 1998, 44 : 873 - 875
  • [37] Levels of serum interleukin (IL)-6, IL-1β, tumour necrosis factor-α and leptin and their correlation in depression
    Yang, Kun
    Xie, Guangrong
    Zhang, Zhongxing
    Wang, Changhong
    Li, Wenbo
    Zhou, Weiqiang
    Tang, Yanqing
    AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY, 2007, 41 (03): : 266 - 273
  • [38] Serum levels of basic fibroblast growth factor and vascular endothelial growth factor in children and adolescents with type 1 diabetes mellitus
    Malamitsi-Puchner, A
    Sarandakou, A
    Tziotis, J
    Dafogianni, C
    Bartsocas, CS
    PEDIATRIC RESEARCH, 1998, 44 (06) : 873 - 875
  • [39] Effect of lowering tumour necrosis factor-α on vascular endothelial function in Type II diabetes
    Bilsborough, W
    O'Driscoll, G
    Stanton, K
    Weerasooriya, R
    Dembo, L
    Taylor, R
    Green, D
    CLINICAL SCIENCE, 2002, 103 (02) : 163 - 169
  • [40] Serum values of tumour necrosis factor-α and of soluble tumour necrosis factor-R55 in melanoma patients
    Ocvirk, J
    Stabuc, B
    Rudolf, Z
    Galvani, V
    Curin-Serbec, V
    MELANOMA RESEARCH, 2000, 10 (03) : 253 - 258